Insider · CIK 0001876041
Mary E. Kissel
Files at QXO (QXO, Inc.), CDRE (Cadre Holdings, Inc.), RXO (RXO, Inc.). First filing -, latest -.
Mary E. Kissel files SEC Form 4 as director at QXO (QXO, Inc.), and also at CDRE (Cadre Holdings, Inc.), RXO (RXO, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mary E. Kissel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | CDRE Cadre Holdings, Inc. | AGrant or award Stock Option (right to purchase)derivative | +17,393 | $0.00 | $0 | 17,393 | Jun 18, 2026 |
| May 5, 2026 | QXO QXO, Inc. | MOption exercise Common Stock, $0.00001 par value | +12,111 | $0.00 | $0 | 37,575 | May 7, 2026 |
| May 5, 2026 | QXO QXO, Inc. | AGrant or award Restricted Stock Unitsderivative | +9,274 | $0.00 | $0 | 9,274 | May 7, 2026 |
| May 5, 2026 | QXO QXO, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,111 | $0.00 | $0 | 0 | May 7, 2026 |
| Jan 2, 2026 | RXO RXO, Inc. | MOption exercise Common Stock | +7,745 | $0.00 | $0 | 35,137 | Jan 6, 2026 |
| Jan 2, 2026 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +14,517 | $0.00 | $0 | 22,262 | Jan 6, 2026 |
| Jan 2, 2026 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -7,745 | $0.00 | $0 | 14,517 | Jan 6, 2026 |
| May 12, 2025 | QXO QXO, Inc. | MOption exercise Common Stock, $0.00001 par value | +14,523 | $0.00 | $0 | 25,464 | May 14, 2025 |
| May 12, 2025 | QXO QXO, Inc. | AGrant or award Restricted Stock Unitsderivative | +12,111 | $0.00 | $0 | 12,111 | May 14, 2025 |
| May 12, 2025 | QXO QXO, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,523 | $0.00 | $0 | 0 | May 14, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | MOption exercise Common Stock | +8,045 | $0.00 | $0 | 27,392 | Jan 6, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +7,745 | $0.00 | $0 | 15,790 | Jan 6, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -8,045 | $0.00 | $0 | 7,745 | Jan 6, 2025 |
Questions about Mary E. Kissel
Answered from the filings on this page, as of the latest one.
Is Mary E. Kissel buying or selling?
Mary E. Kissel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mary E. Kissel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mary E. Kissel has 0.
Where does Mary E. Kissel file Form 4?
Mary E. Kissel has filed Form 4 at QXO (QXO, Inc.); CDRE (Cadre Holdings, Inc.); RXO (RXO, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.